By targeting multiple receptors, Retatrutide aims to provide more comprehensive effects than medications that focus on only one or two pathways
Understanding how these medications function is essential for optimising their use, including determining the most appropriate time of day for administration to maximise therapeutic benefit and minimise adverse effects
It may become available after regulatory reviews are completed
Connect with Affinity Medical Providers and Patient Care Coordinators for a personalized plan delivered to your door
Batches are supported by analytical verification purity assessed by RP-HPLC (above 99% on current batches) and identity confirmed by ESI-TOF mass spectrometry with batch-specific COA, HPLC, and MS reports provided to qualified buyers on request
Retatrutide 10mg -30mg 4.2 out of 5 CAD $100.00 CAD $280.00Price range: CAD $100.00 through CAD $280.00 Retatrutide is a synthetic 39-amino-acid triple receptor agonist supplied lyophilized for in vitro studies of GIP, GLP-1, and glucagon receptor signalling